Award recordCONTRACT

UNITED THERAPEUTICS CORP

PIID VA26016F4140· VHA· 260-NETWORK CONTRACT OFFICE 20 (36C260)· 6810 · CHEMICALS· FY2016· $151,408 net obligations· UEI KK5FBFA43JS7· MD

Description

TYVASO DRUG - CLOSE OUT

Base award description: TYVASO DRUG

First action · last action
2015-10-01 · 2017-03-09
Transactions
2
First transaction's obligation
$178,127
Base + all options value (sum of deltas)
$151,408
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797D40275
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 2 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$178,127$0Base award · 2015-10-01 · this action $178,127 · running total $178,127Modification P00001 · 2017-03-09 · this action -$26,719 · running total $151,408
  • Base2015-10-01+$178,127= $178,127
  • Mod P000012017-03-09-$26,719= $151,408
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2015-10-01+$178,127$178,127TYVASO DRUG
Mod P00001· CLOSE OUT2017-03-09−$26,719$151,408TYVASO DRUG - CLOSE OUT

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI KK5FBFA43JS7)

AwardOffice · PSC / listingNet obligationsFY
36C24526N0777245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$33,158FY2026
36C24526N0755245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$17,352FY2026
36C24526N0754245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$15,746FY2026
36C24526N0723245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$17,352FY2026
36C24526N0722245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$17,352FY2026
36C24526N0707245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$17,352FY2026

Other recipients under 6810 from 260-NETWORK CONTRACT OFFICE 20 (36C260) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C26018P3900LIFE CHEMICALS INC260-NETWORK CONTRACT OFFICE 20 (36C260)$80,976FY2018
VA26018P2530BSE PERFORMANCE, LLC260-NETWORK CONTRACT OFFICE 20 (36C260)$24,960FY2018
VA26017J3080ARIAD PHARMACEUTICALS, INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$79,221FY2017
VA26016F1444LUNDBECK LLC260-NETWORK CONTRACT OFFICE 20 (36C260)$6,829FY2016
VA26016P1112MCKESSON CORPORATION260-NETWORK CONTRACT OFFICE 20 (36C260)$112,285FY2016

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA26016F4140_3600_V797D40275_3600 · retrieved 2026-09-26.